APA (7th ed.) Citation

Li, X., Sun, F., Zhang, X., Lin, P., Shen, K., Shen, Y., . . . Wang, C. (2023). Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: A randomized, double-blind, placebo-controlled phase 1 study. BMC Medicine, 21(1), 1. https://doi.org/10.1186/s12916-023-02834-6

Chicago Style (17th ed.) Citation

Li, Xin, Feifei Sun, Xiaolei Zhang, Pingping Lin, Kai Shen, Yu Shen, Lingyu Ma, Yu Cao, and Chenjing Wang. "Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, an Oral Gonadotropin-releasing Hormone Receptor Antagonist, in Healthy Men: A Randomized, Double-blind, Placebo-controlled Phase 1 Study." BMC Medicine 21, no. 1 (2023): 1. https://doi.org/10.1186/s12916-023-02834-6.

MLA (9th ed.) Citation

Li, Xin, et al. "Safety, Pharmacokinetics, and Pharmacodynamics of SHR7280, an Oral Gonadotropin-releasing Hormone Receptor Antagonist, in Healthy Men: A Randomized, Double-blind, Placebo-controlled Phase 1 Study." BMC Medicine, vol. 21, no. 1, 2023, p. 1, https://doi.org/10.1186/s12916-023-02834-6.